Pediatrix Medical Group Reports Strong Q1 Earnings

Pediatrix Medical Group, Inc. ( (MD) ) has released its Q1 earnings. Here is a breakdown of the information Pediatrix Medical Group, Inc. presented to its investors.

Pediatrix Medical Group, Inc. is a prominent provider of physician services specializing in obstetrics, maternal-fetal medicine, and neonatology, offering care through hospital and office-based practices. In its latest earnings report, Pediatrix Medical Group announced a first-quarter earnings per share of $0.24, with an adjusted EPS of $0.33, reflecting a positive financial performance. Key financial metrics for the first quarter of 2025 include net revenue of $458 million, net income of $21 million, and adjusted EBITDA of $49 million, showcasing growth in same-unit revenue and effective cost management. The company also reported a decrease in practice salaries and benefits expenses, alongside a reduction in general and administrative expenses, contributing to improved profitability. Looking ahead, Pediatrix has raised its full-year 2025 adjusted EBITDA outlook to a range of $220 million to $240 million, indicating confidence in its strategic initiatives despite industry uncertainties.